Patents Assigned to RENEW BIOPHARMA, INC.
  • Variant cannabinoid synthases and methods and uses thereof
    Patent number: 11920166
    Abstract: Described herein are variant, novel cannabinoid synthases, nucleic acids encoding same, and various uses thereof.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: March 5, 2024
    Assignee: RENEW BIOPHARMA, INC.
    Inventors: Kyle Botsch, Craig Behnke, Karla Gonzalez, Matthew Saunders, Michael Mendez
  • Compositions and methods for using genetically modified enzymes
    Patent number: 10894952
    Abstract: The disclosure relates to the biosynthesis of cannabinoids and related prenylated phenolic compounds using recombinant enzymes. In particular, the disclosure provides recombinant mutant ORF2 enzymes engineered to produce a greater amount of a desired product, or to have a greater ability to catalyze a reaction using a desired substrate, as compared to WT ORF2. The disclosure also provides methods of preparing such ORF2 mutant enzymes; as well as methods of use thereof in improving the biosynthesis of cannabinoids and related prenylated phenolic compounds.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: January 19, 2021
    Assignee: RENEW BIOPHARMA, INC.
    Inventors: Michael Mendez, Joseph Noel, Michael Burkart, Jeremy Lanoiselee, Kyle Botsch, Matthew Saunders